High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation for Metastatic Rhabdomyosarcoma—A Systematic Review

@inproceedings{Peinemann2011HighDoseCF,
  title={High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation for Metastatic Rhabdomyosarcoma—A Systematic Review},
  author={Frank Peinemann and Nicolaus Kr{\"o}ger and Carmen Bartel and Ulrich Grouven and Max H. Pittler and Rudolf Erttmann and Michael Kulig},
  booktitle={PloS one},
  year={2011}
}
INTRODUCTION Patients with metastatic rhabdomyosarcoma (RMS) have a poor prognosis. The aim of this systematic review is to investigate whether high-dose chemotherapy (HDCT) followed by autologous hematopoietic stem cell transplantation (HSCT) in patients with metastatic RMS has additional benefit or harm compared to standard chemotherapy. METHODS Systematic literature searches were performed in MEDLINE, EMBASE, and The Cochrane Library. All databases were searched from inception to February… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 99 references

Similar Papers

Loading similar papers…